{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:25:41Z","timestamp":1780395941934,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jvacx.2024.100571","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T19:14:54Z","timestamp":1729019694000},"page":"100571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pulmonary embolism after SARS-CoV-2 vaccination"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1738-0834","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Zethelius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7631-7376","authenticated-orcid":false,"given":"Sofia","family":"Attelind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9402-772X","authenticated-orcid":false,"given":"Gabriel","family":"Westman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-4530","authenticated-orcid":false,"given":"Rickard","family":"Ljung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2337-3371","authenticated-orcid":false,"given":"Anders","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"377","key":"10.1016\/j.jvacx.2024.100571_b0005","doi-asserted-by":"crossref","first-page":"e069590","DOI":"10.1136\/bmj-2021-069590","article-title":"Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study","volume":"6","author":"Katsoularis","year":"2022","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jvacx.2024.100571_b0010","doi-asserted-by":"crossref","first-page":"101669","DOI":"10.1016\/j.cpcardiol.2023.101669","article-title":"Impact of COVID-19 Infection on the Clinical Outcomes of Pulmonary Embolism Hospitalizations : A Nationwide Analysis","volume":"48","author":"Safiriyu","year":"2023","journal-title":"Curr Probl Cardiol"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100571_b0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10140-022-02039-z","article-title":"Incidence of pulmonary embolism in COVID-19 infection in the ED: ancestral, Delta Omicron variants and vaccines","volume":"29","author":"Law","year":"2022","journal-title":"Emerg Radiol"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100571_b0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jvacx.2024.100571_b0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/14760584.2022.2042257","article-title":"Clinical development and approval of COVID-19 vaccines","volume":"21","author":"Kalinke","year":"2022","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.jvacx.2024.100571_b0030","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-062520","article-title":"COVID-19 Vaccine Effectiveness Among Adolescents","volume":"153","author":"Poukka","year":"2024","journal-title":"Pediatrics"},{"issue":"382","key":"10.1016\/j.jvacx.2024.100571_b0035","doi-asserted-by":"crossref","first-page":"e075286","DOI":"10.1136\/bmj-2022-075286","article-title":"Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged 50 years in Nordic countries: nationwide cohort study","volume":"25","author":"Andersson","year":"2023","journal-title":"BMJ"},{"issue":"382","key":"10.1016\/j.jvacx.2024.100571_b0040","doi-asserted-by":"crossref","first-page":"e074325","DOI":"10.1136\/bmj-2022-074325","article-title":"Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses","volume":"24","author":"Andersson","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.jvacx.2024.100571_b0045","first-page":"126","article-title":"The profile of the COvid-19 VACcination register SAFEty study in Sweden (CoVacSafe-SE)","author":"Ljung","year":"2021","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.jvacx.2024.100571_b0050","doi-asserted-by":"crossref","first-page":"100419","DOI":"10.1016\/j.jvacx.2023.100419","article-title":"Nationwide safety surveillance of COVID-19 mRNA vaccines following primary series and first booster vaccination in Singapore","volume":"15","author":"Dorajoo","year":"2023","journal-title":"Vaccine X"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100571_b0055","doi-asserted-by":"crossref","first-page":"e2326852","DOI":"10.1001\/jamanetworkopen.2023.26852","article-title":"Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults","volume":"6","author":"Harris","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"32","key":"10.1016\/j.jvacx.2024.100571_b0060","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1016\/j.vaccine.2023.06.014","article-title":"Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S","volume":"41","author":"Shoaibi","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100571_b0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jama.2021.21699","article-title":"Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older","volume":"327","author":"Jabagi","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jvacx.2024.100571_b0070","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvacx.2024.100571_b0075","unstructured":"Authorized COVID-19 vaccines (updated on 7 may, 2024) COVID-19 medicines|European Medicines Agency (europa.eu)."},{"issue":"1","key":"10.1016\/j.jvacx.2024.100571_b0080","doi-asserted-by":"crossref","first-page":"e12037","DOI":"10.1002\/pul2.12037","article-title":"Validation of the Swedish National Inpatient Register for the diagnosis of pulmonary embolism in 2005","volume":"12","author":"Andersson","year":"2022","journal-title":"Pulm Circ"},{"issue":"6","key":"10.1016\/j.jvacx.2024.100571_b0085","doi-asserted-by":"crossref","first-page":"e2217375","DOI":"10.1001\/jamanetworkopen.2022.17375","article-title":"Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries","volume":"5","author":"Dag Berild","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100571_b0090","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.1038\/s41467-022-34668-w","article-title":"Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom","volume":"13","author":"Burn","year":"2022","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jvacx.2024.100571_b0095","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/14034948221108246","article-title":"Changing characteristics over time of individuals receiving COVID-19 vaccines in Denmark: A population-based descriptive study of vaccine uptake","volume":"50","author":"Reilev","year":"2022","journal-title":"Scand J Public Health"},{"issue":"15","key":"10.1016\/j.jvacx.2024.100571_b0100","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMc2302134","article-title":"Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster","volume":"388","author":"Jabagi","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jvacx.2024.100571_b0105","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/CIRCULATIONAHA.122.060785","volume":"146","author":"Knight","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jvacx.2024.100571_b0110","unstructured":"AstraZeneca\u2019s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets|European Medicines Agency (europa.eu)."},{"issue":"9","key":"10.1016\/j.jvacx.2024.100571_b0115","first-page":"701","article-title":"Thrombotic events and COVID-19 vaccines","volume":"25","author":"Brazete","year":"2021","journal-title":"Lung Dis"},{"issue":"11","key":"10.1016\/j.jvacx.2024.100571_b0120","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/pds.5523","article-title":"Thromboembolic events after Ad.26.COV2.S COVID-19 vaccine: Reports to the Vaccine Adverse Event Reporting System","volume":"31","author":"Woo","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jvacx.2024.100571_b0125","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijid.2022.03.034","article-title":"Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis","volume":"119","author":"Kim","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"373","key":"10.1016\/j.jvacx.2024.100571_b0130","article-title":"Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study","volume":"5","author":"Potteg\u00e5rd","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100571_b0135","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.3390\/ijms24043169","article-title":"A comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology","volume":"24","author":"Pastori","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100571_b0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.advms.2022.10.002","article-title":"Venous thromboembolism: Why is it still a significant health problem?","volume":"68","author":"Oleksiuk-B\u00f3jko","year":"2023","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.jvacx.2024.100571_b0145","unstructured":"Governmental assignment from the Swedish government to the Swedish Medical Products Agency on in depth safety follow-up of vaccines against COVID-19 (Dnr S2020\/08531) \u201cUppdrag om f\u00f6rdjupad s\u00e4kerhetsuppf\u00f6ljning av vacciner mot sjukdomen covid-19 - Regeringen.se\u201d."}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259013622400144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259013622400144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:07:13Z","timestamp":1734480433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259013622400144X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"alternative-id":["S259013622400144X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100571","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary embolism after SARS-CoV-2 vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100571"}}